References
- Dargan PI, Albert S, Wood DM. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. Q J Med 2010; 30 July [Epub ahead of print]. DOI:10.1093/qjmed/hcq134.
- Dick D, Torrance C. MixMag drugs survey. Mix Mag 2010; 225:44–53.
- Erowid 2: 4-Methylmethcathinone reports. http://www.erowid.org/experiences/subs/exp_4Methylmethcathinone.shtml. Accessed 12 August 2010.
- Winstock AR, Mitcheson LR, Deluca P, Davy Z, Corazza O, Schifano F. Mephedrone, new kid for the chop? Addiction 2010; 23 August [Epub ahead of print]. DOI: 10.1111/j.1360-0443.2010.03130.x.
- Wood DM, Greene SL, Dargan PI. Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg Med J 2010; 26 June [Epub ahead of print]. DOI: 10.1136/emj.2010.092288.
- Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, Holt DW, Dargan PI. Purchasing “Legal Highs” on the Internet – Is there consistency in what you get? Q J Med 2010; 103:489–93.
- Ramsey J, Dargan PI, Smyllie M, Davies S, Button J, Holt DW, Wood DM. Buying “legal” recreational drugs does not mean that you aren't breaking the law. Q J Med 2010; 103:777–783.
- Brandt SD, Sumnall HR, Measham F, Cole J. Second generation mephedrone. The confusing case of NRG-1. BMJ 2010; 341:c3564.
- Gibbons S, Zloh M. An analysis of the ‘legal high’ mephedrone. Bioorg Med Chem Lett 2010; 20:4135–4139.
- Europol–EMCDDA Joint Report on a new psychoactive substance: 4-methylmethcathinone (mephedrone). April 2010. http://www.emcdda.europa.eu/attachements.cfm/att_102496_EN_Europol-EMCDDA_Joint_Report_Mephedrone.pdf. Accessed 12 August 2010.
- Statutory Instrument 2010 No:1207. http://www.opsi.gov.uk/si/si2010/uksi_20101207_en_1 . Accessed 12 August 2010.
- Measham F, Moore K, Newcombe R, Welch Z. Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition. Drugs Alcohol Today 2010; 10:14–21.
- Wood DM, Davies S, Puchnaewicz M, Button J, Archer R, Ovaska H, et al. Recreational use of Mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol 2010; 6:327–330.